Virtual agent feasibility in oncology patients (Health Monitoring for Lung Cancer Patients)

What is the Purpose of this Study?

We are doing this study to find out the most preferred method among lung cancer patients for being connected to remote patient monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. We want to find out if patients have an easier, more efficient time setting up these devices by using a virtual interface or with the assistance of a human agent.

What is the Condition Being Studied?

Health Monitoring for Lung Cancer Patients

Who Can Participate in the Study?

Adults ages 18+ who:

  • Are diagnosed with lung cancer
  • Are scheduled to visit the Duke Cancer Center for appointments at least 3 days in a row

For more information, contact the study team at shoem002@mc.duke.edu.

Age Group
Adults

What is Involved?

If you choose to join this study, you will get a random assignment (like a coin flip) to learn about your RPM device through either a virtual agent or a human agent. Your participation will last for 3 days and will include assessments of your medical/oncological history, performance status, body measurements, and vital signs. You will complete onboarding over the phone with the agent you are assigned to and measure your own weight and vital signs with the RPM devices. You will also fill out surveys about your experience.

Study Details

Full Title
A randomized pilot study comparing the feasibility of using a virtual agent vs. an off-site human agent to onboard oncology patients to a remote monitoring device
Principal Investigator
Assistant Professor of Medicine
Protocol Number
IRB: PRO00116186
NCT: NCT06682013
Phase
Phase Pilot
ClinicalTrials.gov
Enrollment Status
INSTITUTIONAL APPROVAL SIGNOFF